The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Daily supplementation with iron plus folic acid, zinc, and their combination is not associated with younger age at first walking unassisted in malnourished preschool children from a deficient population in rural Nepal.
Joanne Katz; Subarna K Khatry; Steven C Leclerq; Luke C Mullany; Elizabeth L Yanik; Rebecca J Stoltzfus; Emily H Siegel; James M Tielsch (Profiled Authors: Joanne Katz; James Tielsch; Luke Mullany; Steven Leclerq; Subarna Khatry)
Department of International Health and; 6Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA.
The Journal of nutrition 2010;140(7):1317-21.
A community-based, cluster-randomized, placebo-controlled trial of daily zinc and/or iron+folic acid supplementation was conducted in rural southern Nepal to examine motor milestone attainment among 3264 children 1-36 mo of age between 2001 and 2006. Treatment groups included placebo, zinc (10 mg), iron+folic acid (12.5 mg iron + 50 microg folic acid), and zinc+iron+folic acid (10 mg zinc + 12.5 mg iron + 50 microg folic acid). Infants received half of these doses. The iron arms were stopped November 2003 by recommendation of the Data Safety and Monitoring Board; zinc and placebo continued until January 2006. A total of 2457 children had not walked at the time of entry into the trial and 1775 were followed through 36 mo. Mean age at first walking unassisted did not differ among groups and was 444 +/- 81 d (mean +/- SD) in the placebo group, 444 +/- 81 d in the zinc group, 464 +/- 85 d in the iron+folic acid group, and 446 +/- 87 d in the iron+folic acid+zinc group. Results were similar after adjustment for age at enrollment, asset ownership, maternal literacy, and prior child deaths in the household and in children who consumed at least 60 tablets. Compared with placebo, iron+folic acid was associated with an adjusted mean delay of 28.0 d (95% CI: 11.3, 44.7) in time to walking among infants and the delay was more pronounced with mid-upper arm circumference (MUAC) < 9.5 cm [60.6 d, (95% CI: 28.5, 92.6)]. Risks and benefits of universal iron+folic acid supplementation of infants beyond improved hematologic status deserve further consideration.
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
P J Surkan; M Shankar; J Katz; E H Siegel; S C Leclerq; S K Khatry; R J Stoltzfus; J M TielschEuropean journal of clinical nutrition 2012;66(7):836-42.
Emily H Siegel; Katarzyna Kordas; Rebecca J Stoltzfus; Joanne Katz; Subarna K Khatry; Steven C LeClerq; James M TielschJournal of health, population, and nutrition 2011;29(6):593-604.
Parul Christian; Christine P Stewart; Steven C LeClerq; Lee Wu; Joanne Katz; Keith P West; Subarna K KhatryAmerican journal of epidemiology 2009;170(9):1127-36.
Appears in this Publication
Author of this Publication